Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity

By sjmartinez • September 20, 2024

Mechanick JI, Butsch WS, Christensen SM, Hamdy O, Li Z, Prado CM, Heymsfield SB. Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity. Obes Rev. 2024 Sep 19:e13841. doi: 10.1111/obr.13841. Epub ahead of print. PMID: 39295512.

Tags: Clinical Nutrition, GLP‐1 receptor agonist, Hospitalist, muscle loss, Nutrition, Publications, resistance training, Veterans Administration

The Role of Precision Nutrition in Kidney Disease

Narasaki Y, Rhee CM, Li Z. The Role of Precision Nutrition in Kidney Disease. Clin J Am Soc Nephrol. 2025 Jul 1. doi: 10.2215/CJN.0000000807. Epub[...]

BCAA catabolism targeted therapy for heart failure with preserved ejection fraction

Wang M, Liu Z, Ren S, Zhu J, Morisawa N, Chua GL, Zhang X, Wong YK, Su L, Wong MX, Yang J, Jens MT, Li[...]

A Qualitative Study of Collaborative Food Programs: Insights from a FQHC-University Partnership During COVID-19

Kim M, Thang CK, Imai L, Corwin M, Adeyemo MA, Imbery C, Boyce S, Garell CL, Slusser WM, Guerrero AD. A Qualitative Study of Collaborative[...]